ALS2CL
Basic information
Region (hg38): 3:46668995-46693704
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Schizophrenia | AD | General | Evidence or clinical applicability is unclear | Neurologic | 21743468; 23425335 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALS2CL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 59 | 63 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 60 | 4 | 0 |
Variants in ALS2CL
This is a list of pathogenic ClinVar variants found in the ALS2CL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-46670994-T-A | not specified | Uncertain significance (Dec 08, 2023) | ||
3-46671024-T-C | not specified | Uncertain significance (Mar 03, 2022) | ||
3-46671542-C-G | not specified | Uncertain significance (Jan 11, 2023) | ||
3-46671891-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
3-46671984-C-T | not specified | Uncertain significance (Jan 24, 2023) | ||
3-46671984-CG-C | not specified | Uncertain significance (Mar 29, 2016) | ||
3-46672028-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
3-46672031-G-A | not specified | Uncertain significance (Apr 16, 2024) | ||
3-46672143-A-T | not specified | Uncertain significance (Sep 16, 2021) | ||
3-46672180-T-C | not specified | Uncertain significance (Apr 17, 2024) | ||
3-46674704-A-T | not specified | Uncertain significance (Dec 02, 2021) | ||
3-46675627-G-C | not specified | Uncertain significance (May 28, 2024) | ||
3-46675660-C-T | not specified | Uncertain significance (Apr 18, 2023) | ||
3-46675661-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
3-46675675-C-T | not specified | Likely benign (Nov 18, 2023) | ||
3-46676294-C-T | not specified | Uncertain significance (Mar 11, 2022) | ||
3-46676300-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
3-46676321-C-T | not specified | Uncertain significance (Dec 05, 2022) | ||
3-46676362-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
3-46676667-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
3-46676671-G-A | not specified | Uncertain significance (May 20, 2024) | ||
3-46676707-C-T | not specified | Uncertain significance (Feb 10, 2023) | ||
3-46676725-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
3-46676873-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
3-46676886-C-T | not specified | Uncertain significance (Nov 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ALS2CL | protein_coding | protein_coding | ENST00000318962 | 25 | 24708 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.30e-28 | 0.00357 | 125023 | 4 | 720 | 125747 | 0.00288 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.169 | 553 | 564 | 0.980 | 0.0000354 | 6110 |
Missense in Polyphen | 152 | 178.1 | 0.85344 | 2030 | ||
Synonymous | 0.649 | 241 | 254 | 0.948 | 0.0000167 | 1922 |
Loss of Function | 1.04 | 47 | 55.4 | 0.849 | 0.00000271 | 597 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00256 | 0.00255 |
Ashkenazi Jewish | 0.00120 | 0.00119 |
East Asian | 0.00305 | 0.00305 |
Finnish | 0.00495 | 0.00491 |
European (Non-Finnish) | 0.00285 | 0.00276 |
Middle Eastern | 0.00305 | 0.00305 |
South Asian | 0.00431 | 0.00429 |
Other | 0.00425 | 0.00424 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a guanine nucleotide exchange factor (GEF) for Rab5 GTPase. Regulates the ALS2-mediated endosome dynamics. {ECO:0000269|PubMed:15388334, ECO:0000269|PubMed:16473597, ECO:0000269|PubMed:17239822}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Rab regulation of trafficking;RAB GEFs exchange GTP for GDP on RABs
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.956
- rvis_EVS
- -0.92
- rvis_percentile_EVS
- 9.81
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- N
- hipred_score
- 0.377
- ghis
- 0.508
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.654
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Als2cl
- Phenotype
Gene ontology
- Biological process
- endosome organization;positive regulation of GTPase activity
- Cellular component
- cytosol
- Molecular function
- GTPase activator activity;Rab guanyl-nucleotide exchange factor activity;identical protein binding